Dr. Ogün Sazova has graduated Istanbul University Faculty of Medicine and has a specialization degree for family medicine. After spending 5 years in clinical and research setting in Turkey and Germany, he joined pharmaceutical industry in 2003 and worked in local medical and commercial roles before joining AstraZeneca (AZ) Turkey as the Head of Primary Care Medical Affairs. In this role, Ogün has built the MSL function in AZ Turkey amongst other medical affairs deliverables. In 2009, Ogün moved to EU regional organization in Brussels and was the EU Medical Affairs Director for Cardiovascular Diseases for AZ. In 2012, he was appointed as the Global Nominated Signatory Practice Director in Global Medical Excellence group, and moved to London with his family. In this role, Ogün has set standards for Nominated Signatory operations worldwide, including risk & control framework, training, accreditation, and many examples of simplification. After this role, Ogün has taken over the lead of the Global Medical Academy and established it as a centre of excellence in AZ to drive world-class scientific engagements by medical teams in the countries. In his final role with AZ, Ogün worked in Rheumatology & Inflammation therapy area and moved to Napp Pharmaceuticals in January 2020, where he is currently working as the Country Medical Director for the UK & Ireland.